Therapeutic advances targeting tumor angiogenesis in pancreatic cancer: current dilemmas and future directions
YF An, N Pu, JB Jia, WQ Wang, L Liu - Biochimica et Biophysica Acta (BBA) …, 2023 - Elsevier
Pancreatic cancer (PC) is one of the most lethal malignancies, which is generally resistant to
various treatments. Tumor angiogenesis is deemed to be a pivotal rate-determining step for …
various treatments. Tumor angiogenesis is deemed to be a pivotal rate-determining step for …
The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
D Li, X Chu, W Liu, Y Ma, X Tian, Y Yang - RNA biology, 2025 - Taylor & Francis
The crosstalk between the tumour immune microenvironment (TIME) and tumour cells
promote immune evasion and resistance to immunotherapy in gastrointestinal (GI) tumours …
promote immune evasion and resistance to immunotherapy in gastrointestinal (GI) tumours …
Bioreactor-based stem cell therapy for liver fibrosis
M Yan, J Yao, Y Xie, P Jiang, J Yan, X Li - Biofabrication, 2024 - iopscience.iop.org
Stem cell therapy, achieved using mesenchymal stem cells (MSCs), has been highlighted
for the treatment of liver fibrosis. Infusion into the circulatory system is a traditional …
for the treatment of liver fibrosis. Infusion into the circulatory system is a traditional …
[HTML][HTML] Honey Targets Ribosome Biogenesis Components to Suppress the Growth of Human Pancreatic Cancer Cells
AA Bangash, SS Alvi, MA Bangash, H Ahsan… - …, 2024 - pmc.ncbi.nlm.nih.gov
Simple Summary Pancreatic cancer (PanCa) is one of the deadliest forms of cancer with
limited therapeutic options. The available conventional therapies are highly toxic and often …
limited therapeutic options. The available conventional therapies are highly toxic and often …
Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies
S Guo, Z Wang - Frontiers in Oncology, 2024 - frontiersin.org
Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), stands as the
fourth leading cause of cancer-related deaths in the United States, marked by challenging …
fourth leading cause of cancer-related deaths in the United States, marked by challenging …
Matrix stiffness regulates the protein profile of extracellular vesicles of pancreatic cancer cell lines
B Ferrara, S Bourgoin‐Voillard, D Habert, B Vallée… - …, 2024 - Wiley Online Library
The fibrotic stroma characterizing pancreatic ductal adenocarcinoma (PDAC) derives from a
progressive tissue rigidification, which induces epithelial mesenchymal transition and …
progressive tissue rigidification, which induces epithelial mesenchymal transition and …
A Non‐G‐Quadruplex DNA Aptamer Targeting NCL for Diagnosis and Therapy in Bladder Cancer
Y Liu, B Hu, X Pei, J Li, D Qi, Y Xu, H Ou… - Advanced …, 2023 - Wiley Online Library
Bladder cancer (BC) is a highly aggressive malignant tumor affecting the urinary system,
characterized by metastasis and a poor prognosis that often leads to limited therapeutic …
characterized by metastasis and a poor prognosis that often leads to limited therapeutic …
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
M Ponzo, A Debesset, M Cossutta, M Chalabi-Dchar… - Cancers, 2022 - mdpi.com
Cancers | Free Full-Text | Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases
Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265 Next Article in Journal …
Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265 Next Article in Journal …
TNFR2 blockade promotes anti-tumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion
A Debesset, C Pilon, S Meunier, O Bonizec, W Richer… - bioRxiv, 2024 - biorxiv.org
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, highly
resistant to standard chemotherapy and immunotherapy. Regulatory T cells (Tregs) …
resistant to standard chemotherapy and immunotherapy. Regulatory T cells (Tregs) …
[PDF][PDF] Semaphorin 3A reprograms the tumor microenvironment “ecosystem” in pancreatic cancer
CF Cojocaru - 2023 - iris.unito.it
ABSTRACT Pancreatic Ductal Adenocarcinoma (PDAC) is considered a major public health
concern globally due to its delayed diagnoses and to the almost absent repertoire of …
concern globally due to its delayed diagnoses and to the almost absent repertoire of …